We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners
News

Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners

Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners
News

Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

MedBiomix Partners SAS and Proteome Sciences Ltd have announced that they enter into a collaborative network alliance, whose goal is to provide healthcare professionals with advanced data-driven solutions to integrate and make better use of protein expression data that will significantly improve the life and disease conditions of their patients.

“The understanding of human disease and execution of personalized medicine requires the use of multi-scale analysis”, says Patrice Denèfle, Co-founder of MedBiomiX Partners, “we are delighted to engage with Proteome Sciences as a new partner in our growing network of excellence as their knowledge in measurement of protein expression and post-translational modifications will bring an additional, very important dimension to our set of expertise beyond DNA and RNA analysis”.

Ian Pike, Chief Operating Officer of Proteome Sciences added: “We are excited to join the MedBiomix network which will further extend the reach of our powerful proprietary tools and technologies to support and enhance the development and delivery of personalized medicine approaches to improve treatment programmes for patients with cancer and neurological conditions.”

Advertisement